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To date, more than 40 different types of cells from primary cultures or cell lines have
shown AChE expression during apoptosis and after the induction apoptosis by different
stimuli. It has been well-established that increased AChE expression or activity is detected
in apoptotic cells after apoptotic stimuli in vitro and in vivo, and AChE could be therefore
used as a marker of apoptosis. AChE is not an apoptosis initiator, but the cells in which
AChE is overexpressed undergo apoptosis more easily than controls. Interestingly, cells
with downregulated levels of AChE are not sensitive to apoptosis induction and AChE deﬁ-
ciency can protect against apoptosis. Some tumor cells do not express AChE, but when
AChE is introduced into a tumor cell, the cells cease to proliferate and undergo apopto-
sis more readily. Therefore, AChE can be classiﬁed as a tumor suppressor gene. AChE
plays a pivotal role in apoptosome formation, and silencing of the AChE gene prevents
caspase-9 activation, with consequent decreased cell viability, nuclear condensation, and
poly (adenosine diphosphate-ribose) polymerase cleavage. AChE is translocated into the
nucleus, which may be an important event during apoptosis. Several questions still need
to be addressed, and further studies that address the non-classical function of AChE in
apoptosis are needed.
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The human gene that encodes acetylcholinesterase (AChE) is
located on chromosome 7q22 (Ehrlich et al., 1992; Getman et al.,
1992).Acetylcholinesterase is a typeB carboxylesterase that rapidly
hydrolyzes the neurotransmitter acetylcholine (ACh) at choliner-
gic synapses, as well as at neuromuscular junctions (Grisaru et al.,
1999; Sperling et al., 2008). Additional splice variants involving
both the 5′ and 3′ ends of the gene have also been reported. Among
these splice variants are three distinct AChE variants, each with a
different carboxyterminal sequence, called the“synaptic”(S),“ery-
throcytic” (E), and “readthrough” (R) AChE isoforms (Soreq and
Seidman, 2001; Meshorer and Soreq, 2006). “Synaptic” AChE-S
constitutes the principal multimeric enzyme in brain and mus-
cle; soluble,monomeric “readthrough”AChE-R has been reported
in embryonic and tumor cells and is induced under psycholog-
ical, chemical, and physical stress; and ﬁnally, glypiated dimers
of erythrocytic AChE-E are associated with red blood cell mem-
branes (Grisaru et al., 1999). In addition to its catalytic function
of the hydrolysis of acetylcholine, AChE has been shown to be
involved in many non-cholinergic functions, such as cell growth,
stem cell differentiation (Sperling et al., 2008), neuritogenesis,
cell adhesion (Paraoanu and Layer, 2008), synaptogenesis, activa-
tion of dopamine neurons, tumorigenesis, amyloid ﬁber assembly
Abbreviations: AChE, acetylcholinesterase; AChE-E, erythrocytic acetyl-
cholinesterase; AChE-S, synaptic acetylcholinesterase; AChE-R, readthrough
acetylcholinesterase; AML, acute myeloid leukemia; BuChE, butyrylcholinesterase;
HCC, human colorectal carcinoma; Icv, intracerebroventricular; RA, refractory
anemia; TGF-β, transforming growth factor-beta; TGF-α, transforming growth
factor-alpha; TgS mice, transgenic mice overexpressing AChE-S.
(Inestrosa et al., 1996; Alvarez et al., 1997), hematopoiesis, and
thrombopoiesis (Greenﬁeld, 1996; Layer, 1996; Small et al., 1996;
Soreq and Seidman, 2001). Almost a decade ago, work by our
group revealed that AChE-S expression can be induced during
apoptosis in various cell types, including cells that did not orig-
inate from the nervous or hematopoietic system (Zhang et al.,
2002). It has also been shown that AChE exerts its pivotal role in
apoptosis by its participation in the formation of the apoptosome
(Park et al., 2004). In this review we will summarize the functional
evidence for the role of AChE during apoptosis, despite the fact
that our understanding of the apoptotic role of AChE is still not
complete.
AChE LEVELS ARE INCREASED IN APOPTOTIC CELLS AFTER
APOPTOTIC STIMULI BOTH IN VITRO AND IN VIVO
AChE is expressed in cholinergic neurons, neuromuscular junc-
tions, hematopoietic cells, including erythrocytes (Grisaru et al.,
1999) and megakaryocytes (Paulus et al., 1981; Tranumjensen and
Behnke,1981), aswell tissues that are not innervated by cholinergic
neurons (Small et al., 1996). There is mounting evidence, however,
that AChE expression is induced during apoptosis in a variety of
other cell types (Zhang et al., 2002). Human lung ﬁbroblast (HLF)
cells and rat kidney (NRK) cells do not normally express AChE,
but have been shown to express high levels of AChE when under-
going apoptosis or when moving from an inactive to an active state
(Zhang et al., 2002; Jin et al., 2004). In general, cells that normally
express low levels of AChE, such as PC-12, showed increased lev-
els of AChE and AChE activity whilst undergoing apoptosis (Yang
et al., 2002; Jing et al., 2008). Steinritz et al. (2007) reported that
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increasedAChE activity was found in sulfur mustard (SM)-treated
A549 cell culture, as determined by Ellman assay andWestern blot-
ting. Interestingly, AChE activity showed a strong correlation with
the number of TUNEL-positive cells. Furthermore, AChE activity
maybe apotentialmarker of apoptosis inA549 cells after SM injury
(Steinritz et al., 2007).Other diseases with a possible apoptotic role
in disease pathogenesis such as Alzheimer’s disease and diabetes
also show cholinesterase involvement. Allam et al. observed that
butyrylcholinesterase andAChE-related proteins were found to be
common to both Alzheimer’s disease and diabetes; these proteins
may play an etiological role via their inﬂuence on insulin resis-
tance and lipidmetabolism (Allam et al., 2006). Toiber et al. (2008)
showed that in transfected primary brain cultures, an alternative
N terminal extended transcript of AChE (N-AChE-S) induced cell
death, morphological impairments and caspase-3 activation. In
addition in cortical tissues from AD patients, N-AChE-S over-
expression coincides with Tau hyper-phosphorylation. In other
pathologies, Hu et al. (2009) showed increased expression lev-
els of AChE and caspase-3 in the brain and peripheral immune
system of focal cerebral ischemic rats. Xiao et al. (2006) utilized
AChE with Bax, c-fos, and p53 genes as markers of apoptosis.
Huang et al. (2005) have developed a novel assay that utilizes
ﬂuorochrome-tagged physostigmine (Ph-F) in situ to detect active
AChE that has been induced during apoptosis. Cells that show an
increase in AChE activity during apoptosis are summarized in
Table 1.
CELL SENSITIVITY TO APOPTOSIS IS RELATED TO AChE
EXPRESSION LEVELS
AChE is not a universal activators of apoptosis as it has been well-
established that cholinergic neurons and neuromuscular junctions
that express AChE do not initiate apoptosis under normal con-
ditions without an apoptotic stimulus. However, AChE-positive
cells, such as PC-12 (Yang et al., 2002; Jing et al., 2008) as
well as neurons have been shown to respond more sensitively
to apoptotic stimuli than AChE-negative cells (Jin et al., 2002,
2004). To investigate this, a stable cell line that overexpressed
AChE was established from NRK cells. Overexpression of AChE
was shown to inhibit cell proliferation and promote apoptosis
in these cells. Transgenic mice which overexpress catalytically
active AChE-S and have a higher levels of AChE hydrolytic activ-
ity than control mice, show increased levels of cell labeling by
both bromodeoxyuridine and caspase-3; which reﬂects increased
neural apoptosis (Cohen et al., 2008) though these transgenic
mice also showed increased neuronal survival through an as yet
unidentiﬁed compensatory mechanism. AChE was also shown
to suppress cell proliferation via catalytic hydrolysis of acetyl-
choline in human colorectal carcinoma (HCC) (Montenegro et al.,
2006).
Zhang et al. (2002) showed that the downregulation of AChE
expression with antisense inhibited apoptosis, and they suggest
that AChE is potentially a marker and a regulator of apopto-
sis. Park et al. (2004) explored the role of AChE in apoptosis by
silencing the AChE gene. Silencing of AChE abolished the expres-
sion of AChE and prevented caspase-9 activation, decreased cell
viability, nuclear condensation, and poly(adenosine diphosphate-
ribose) polymerase cleavage. Animal models of degenerative
diseases were found to bemore easily established inAChE+/+ mice
than AChE+/− mice. Espallergues et al. (2010) showed that the
intracerebroventricular injection of amyloid-beta (25–35) failed
to induce learning deﬁcits in AChE+/− mice, but impaired learn-
ing in AChE+/+ controls. The peptide showed reduced toxicity in
the forebrain structures of AChE+/− mice, as an increase in lipid
peroxidation levelswasmeasured in the hippocampus of AChE+/+
butnotAChE+/− mice. They concluded that the increase in cholin-
ergic tonus observed in AChE+/− mice did not result in increased
memory functions but allowed a signiﬁcant prevention of the
deleterious effects of muscarinic blockade or amyloid toxicity.
Ye et al. (2010) recently reported that AChE is expressed dur-
ing ischemia–reperfusion (I/R)-induced apoptosis in vivo. Their
study demonstrated that AChE may be a pro-apoptotic factor
and that the inhibition of AChE reduces the degree of renal I/R
injury.
AChE AND TUMOR SUPPRESSION
Papers reporting the presence of AChE in tumors have ﬁrst been
reported almost 40 years ago (Gearhart and Mintz, 1974). The
exact role of AChE in oncogenesis or tumor progression is still
unclear and beyond the scope of this review. However a num-
ber of studies (Gearhart and Mintz, 1974; Takahashi et al., 1995;
Johnson and Cotter, 1997) have shown an genetic alterations in
the long arm of chromosome 7 the genetic locus of the AChE
gene, in several tumors. Furthermore, the agricultural use of
AChE inhibitors is known to induce several types of tumors (Dich
et al., 1997; Cabello et al., 2001; Abou-Donia, 2003). Stephenson
et al. (1996) investigated gene copy-number alterations at these
genes in myelodysplastic syndrome (MDS) and acute myeloid
leukemia (AML). These data raise the intriguing possibility that
the proaptotic role of AChE could play a role in tumor suppressor.
(Stephenson et al., 1996).
Cholinesterases are downregulated in HCC (Montenegro et al.,
2006), squamous cell carcinoma, and retinoblastoma (Qavi and
Al-Rajhi, 2009). Zhao et al. (2011) demonstrated that AChE was
signiﬁcantly downregulated in the cancer tissues of 69.2% of HCC
patients, and the low level of AChE expression in HCC was corre-
lated with tumor aggressiveness, the elevated risk of postoperative
recurrence, and a low survival rate. Both the recombinant AChE
protein and the enhanced expression of AChE signiﬁcantly inhib-
ited HCC cell growth in vitro and tumorigenicity in vivo. The
studies describe the function of AChE as a tumor growth sup-
pressor that acts in the regulation of cell proliferation, relevant
signaling pathways, and the chemosensitivity of HCC cells. AChE
is a promising independent prognostic predictor for HCC recur-
rence and the survival of HCC patients (Montenegro et al., 2006).
AChE-R was shown to increases germ cell apoptosis (Mor et al.,
2008).
LOCALIZATION OF AChE TO THE CELL NUCLEUS AND
APOPTOTIC BODIES MAY PLAY A ROLE IN APOPTOSIS
INDUCTION
Zhang et al. (2002) have shown by cytochemical staining
and immunohistochemistry that the presence of AChE is not
homogeneous in either the cytoplasm or in the nucleus. To
establish whether this heterogeneity is due to the stage of
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Table 1 | Summarized cell lines in which AChE expression or activity were increased by the apoptotic stimuli with various apoptotic inducers.
Cell type Apoptotic inducer Increase of AChE
expression or activity
Reference
A549 Sulfur mustard Yes Steinritz et al. (2007)
Animal brain HBP hypobaric hypoxia (HBH) Yes Muthuraju et al. (2009)
Brain tissue of rats Ischemia Yes Hu et al. (2009)
BRL Detachment Yes Zhang et al. (2002)
C57BL/6J beta cells Streptozotocin Yes Zhang et al. (2012)
Dami TGFβ Yes Zhang et al. (2002)
EC prim. bovine endothelial cell TGFβ Yes Zhang et al. (2002)
EC prim. swine endothelial cell Detachment Yes Zhang et al. (2002)
HEK293T H2O2, cisplatin Yes Zhang et al. (2008), Gong et al. (2009)
HEL Huangqi (Hex) Yes Cheng et al. (2004)
HeLa A23187, thapsigargin, topotecan, H2O2,
TNFα+CHX
Yes Zhang et al. (2002), Huang et al. (2005);
Gao et al. (2009), Zhu et al. (2007a,b,c)
HFL-1 Aging Yes Zhang et al. (2002)
HL-60 Topotecan, H2O2, Daunorubicin Yes Zhang et al. (2002), Huang et al. (2005)
HLF Aging Yes Zhang et al. (2002), Jin et al. (2002)
HOS TGFβ Yes Zhang et al. (2002)
HT-29 Etoposide Yes Park et al. (2004, 2008)
HUVEC Serum-starved medium Yes Xie et al. (2011)
IL-3-deprived (murine) bone marrow
derived mast cells
A nitric oxide donor Yes Park et al. (2008)
Jarkat Cell Topotecan, H2O2 Yes Huang et al. (2005)
K562 Huangqi (Hex) Yes Cheng et al. (2004)
Lymphocytes Post partum Yes Pick et al. (2004)
M07e Minus GM-CSF Yes Zhang et al. (2002)
Malme-3M Etoposide Yes Park et al. (2008)
MDA-MB-435s A23187, thapsigargin Yes Zhu et al. (2007c)
Meg-01 TGFβ Yes Zhang et al. (2002)
Mouse hippocampal granule cells
fromTgs mice
Tgs Yes Cohen et al. (2008)
Myoblast Staurosporine AChE-R Pegan et al. (2010)
NIH/3T3 Detachment Yes Zhang et al. (2002)
MIN6 cells Streptozotocin Yes Zhang et al. (2012)
NRK G418 Yes Jin et al. (2004)
Osteoblast Long-term culture Yes Gu et al. (2002)
PC-12 H2O2, A23187, thapsigargin Yes Jing et al. (2008), Jiang et al. (2007)
PC-3 TGFβ Yes Zhang et al. (2002)
Primary cortical neuron Sodium selenite Yes Xiao et al. (2006)
Primary cultured rat articular
chondrocytes
Infected with 100 MOI adenoviral TRAIL Yes Park et al. (2008)
Rat kidney Ischemia/reperfusion Yes Ye et al. (2010)
Rat smooth muscle TGF-β Yes Zhang et al. (2002)
Raw264.7 SIN-1, a nitric oxide donor Yes Park et al. (2008)
Retinal Light-induced retinal damage Yes Kehat et al. (2007)
SH-SY5Y Tertiary butylhydroperoxide N-AChE Kehat et al. (2007)
SK-MEL-5 Etoposide Yes Park et al. (2008)
SK-N-SH TNFα+CHX Yes Zhang et al. (2002)
(Continued)
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Table 1 | Continued
Cell type Apoptotic inducer Increase of AChE
expression or activity
Reference
SW620 cells Etoposide, excisanin A Yes Deng et al. (2006)
TE671 Etoposide Yes Park et al. (2008)
U373MG Etoposide Yes Park et al. (2008)
HUVEC, human umbilical vein endothelial cells.
apoptosis induction, the authors examined the time course of
AChE expression in the leukemic Meg-01 cell line after treat-
ment with transforming growth factor (TGF)-β. Cytochemical
staining showed AChE initially appears in the cytosol and after-
ward in the nucleus. AChE-positive staining follows the nuclear
morphological changes such as condensation and fragmentation.
Eventually, when the cell membrane ruptures, AChE is released.
They also examined the expression of AChE by transmission elec-
tronmicroscopy.At 2 h after TGF-β treatment,AChEwas observed
only in the cytosol but by 4 h had moved entirely to the nucleus.
Therefore, during the induction of apoptosis, AChE is ﬁrst syn-
thesized in the cytosol and then accumulates in the nucleus. In
general AChE is present in the nucleus at the mid- and late-stages
of apoptosis (Yang et al., 2002; Jin et al., 2004; Xie et al., 2011). San-
tos et al. (2007) initially investigated the expression and subcellular
localization of acetylcholinesterase (AChE) in endothelial cells and
showed the expression of a 70-kDa AChE in both the cytoplasmic
and nuclear compartments. The levels of this novel isoform are
decreased in response to vascular endothelial growth factor via the
proteasome pathway. They found that AChE was downregulated
in human leukemic T cells compared with normal T cells, which
suggested that the decreased expression of the 55-kDa AChE pro-
tein may contribute to an angiogenic response and be associated
with tumorigenesis. Importantly, nuclear expression is not speciﬁc
to endothelial cells, but is also present in non-neuronal and neu-
ronal cells. Xie et al. (2011) showed that the 55-kDa AChE protein
was induced during apoptosis and was negatively regulated by the
Akt pathway. PC-12 express AChE at basal levels in normal cells,
but a 55-kDa AChE protein can be found during the progression
of apoptosis. This 55 kDa AChE protein was temporally expressed
after the activation of caspases and was caspase-dependent. The
inhibition of protein synthesis with CHX indicated that the 55-
kDa AChE protein resulted from the cleavage of the 68-kDa AChE
(Xie et al., 2011). There are still questions regarding AChE that
need to be addressed, including its function when it enters the
nucleus. Furthermore, whether AChE entry into the nucleus is an
active or passive event, how is it transported and what is the signal
that allows it to enter the nucleus are all questions which still need
to be resolved.
AChE COULD PLAYS A PIVOTAL ROLE IN THE FORMATION OF
APOPTOSOMES
The role of AChE in apoptosis is a key question in this ﬁeld.
Park et al. (2004) showed that silencing of the AChE gene inhib-
ited the interaction between Apaf-1 and cytochrome c. They
concluded that AChE plays an important role in apoptosome
formation. Their data showed that an antisense AChE oligonu-
cleotide showed a similar effect by silencing the AChE gene.
Small interfering RNA (siRNA) against the cytochrome c gene
blocked the interaction of AChE with Apaf-1, whereas siRNA tar-
geting the Apaf-1 gene did not block the interaction of AChE
with cytochrome c. These ﬁndings indicated that the interac-
tion of AChE with cytochrome c is required for the interaction
between cytochrome c and protease-activating factor-1. Park et al.
(2008) also showed that the interactions of AChE with caveolin-1
and, subsequently with cytochrome c, appear to be indispensable
for the formation of apoptosomes. To date, however, these ﬁnd-
ings have only been shown in one study and more evidence is
required to conﬁrm how AChE participates in the formation of
the apoptosome.
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